News

Rep. Charles Gonzalez introduced this bill on January 26, 201It has since been referred to the Ways and Means Subcommittee on Social Security and to the Committee on Education and the Workforce..The fight over ending surprise billing has sparked a costly lobbying fight from hospital and doctors groups as well as insurers which oppose ending the practice. That's who TSCL is up against in this fight and it's why your support is so important to our work..New Alzheimer's Drug Sparks Controversy.We have been hearing from hundreds of you who are watching the inflation numbers and eagerly looking forward to getting a high inflation boost next year. But a number of you point out an urgent problem that occurs when COLAs raise the income of people with lower incomes. The higher inflation boost can sometimes disqualify people of modest means from receiving low-income benefits such as food stamps or rental assistance..Flu vaccination has many benefits. It has been shown to reduce flu illnesses and also to reduce the risk of more serious flu outcomes that can result in hospitalization or even death in older people. Flu vaccination has been shown in several studies to reduce severity of illness in people who get vaccinated but still get sick..I remain committed to determining the causes of rising drug prices and identifying potential solutions to reduce costs for American families. Everyone deserves access to health care that will improve their lives. Health care is a right, not a privilege, and I pledge to do all I can to protect this right..This order is not only vehemently opposed by the pharmaceutical industry but also by many conservative groups that have otherwise been supportive of Trump during his time in office..To improve program solvency, TSCL's surveys have found that a large majority of survey participants, 72%, support applying the Social Security payroll tax to all earnings instead of just the first 2,800 in earnings..Now, 18 years later, TSCL is hopeful that 2021 will be the year when Congress finally enacts legislation to allow Medicare to negotiate drug prices with pharmaceutical companies. This change is supported by about 85% of participants in TSCL's Senior Surveys. In 2019, Congress came very close to passing such a bill. In 2019, the House passed legislation, that would have allowed Medicare to negotiate drug prices, but was loathed by the pharmaceutical industry. It stalled in the Senate late in 2019 when Senate leadership refused to take up the bill.